Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenalized methylene blue and adrenalized Marcaine for pain relief after hemorrhoidectomy
IRCT20190325043107N27Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylene blue and bupivacaine in postoperative pain, sponsored by Tabriz University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
methylene bluebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190325043107N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N27.